EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency BusinessWire - Fri Feb 26, 5:30AM CST CMTX - Fri Feb 26, 5:30AM CST
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for somatrogon,...
Medical And Diagnostic Laboratory Services Global Market Report 2021: COVID 19 Impact and Recovery to 2030 GlobeNewswire - Wed Feb 24, 6:37AM CST CMTX - Wed Feb 24, 6:37AM CST
Reportlinker.com announces the release of the report "Medical And Diagnostic Laboratory Services Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027722/?utm_source=GNW...
Enormous Growth of Global Prostate Cancer Diagnostics Market | Including Top Players like Abbott, MDxHealth, Genomic Health, 3D Signatures, OPKO Health, INC., Siemens Healthcare GmbH, DiaSorin S.p.A, F. Hoffman La Roche Ltd Heraldkeepers - Mon Feb 22, 9:34AM CST CMTX - Mon Feb 22, 9:34AM CST
Â
New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy PR Newswire - PRF - Mon Feb 22, 7:38AM CST CMTX - Mon Feb 22, 7:38AM CST
, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locations offering COVID-19...
OPKO Health (OPK) Q4 Earnings and Revenues Beat Estimates Zacks - Fri Feb 19, 4:57AM CST Zacks Equity Research - ZACKS - Fri Feb 19, 4:57AM CST
OPKO Health's (OPK) fourth-quarter results benefit from strength in diagnostics.
OPKO Health (OPK) Q4 Earnings and Revenues Surpass Estimates Zacks - Thu Feb 18, 4:45PM CST Zacks Equity Research - ZACKS - Thu Feb 18, 4:45PM CST
OPKO Health (OPK) delivered earnings and revenue surprises of 25.00% and 13.41%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
OPKO Health: 4Q Earnings Snapshot AP - Thu Feb 18, 3:47PM CST APAI - Thu Feb 18, 3:47PM CST
MIAMI (AP) _ Opko Health Inc. (OPK) on Thursday reported fourth-quarter net income of $32.3 million, after reporting a loss in the same period a year earlier.
OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results GlobeNewswire - Thu Feb 18, 3:09PM CST CMTX - Thu Feb 18, 3:09PM CST
OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2020.
OPKO Health (OPK) to Report Q4 Earnings: What's in Store? Zacks - Mon Feb 15, 10:08AM CST Zacks Equity Research - ZACKS - Mon Feb 15, 10:08AM CST
OPKO Health's (OPK) fourth-quarter results are likely to reflect solid performance from Services and Products segment and RAYALDEE.
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021 GlobeNewswire - Wed Feb 3, 8:01AM CST CMTX - Wed Feb 3, 8:01AM CST
OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2020, as well as discuss financial guidance, after the close of the U.S. financial...
New Drug Application Submitted to PMDA in Japan for Somatrogon, to Treat Pediatric Patients with Growth Hormone Deficiency GlobeNewswire - Thu Jan 28, 7:07AM CST CMTX - Thu Jan 28, 7:07AM CST
OPKO Health, Inc. (NASDAQ: OPK) announced today that its partner, Pfizer Japan Inc., submitted a New Drug Application (NDA) to the Ministry of Health, Labour, and Welfare in Japan for somatrogon, a long-acting...
OPKO Health's GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia PR Newswire - PRF - Tue Jan 26, 7:30AM CST CMTX - Tue Jan 26, 7:30AM CST
, /PRNewswire/ --Â GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched several new genetic tests, including repeat expansion...
OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing PR Newswire - PRF - Tue Jan 26, 7:01AM CST CMTX - Tue Jan 26, 7:01AM CST
, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced COVID-19 testing agreements for players and officials, as well as team and league staff for the...
OPKO Health's (OPK) BioReference Extends Digital Health Access Zacks - Thu Jan 14, 8:46AM CST Zacks Equity Research - ZACKS - Thu Jan 14, 8:46AM CST
OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.
OPKO Health's BioReference Laboratories Introduces Scarlet Healthâ„¢, an In-Home Diagnostic Service to Expand Digital Health Access PR Newswire - PRF - Wed Jan 13, 2:40PM CST CMTX - Wed Jan 13, 2:40PM CST
, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced , an in-home, fully integrated digital platform providing access to on-demand diagnostic...
Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q'20 Guidance GlobeNewswire - Wed Jan 13, 5:00AM CST CMTX - Wed Jan 13, 5:00AM CST
Sian Capital, LLC (together with its affiliates, "Sian" or "we"), a sizable stockholder of OPKO Health, Inc. (NASDAQ: OPK) ("OPKO" or the "Company"), today announced that it sent a letter to the Company's...
OPKO Health (OPK) Outpaces Stock Market Gains: What You Should Know Zacks - Thu Jan 7, 4:45PM CST Zacks Equity Research - ZACKS - Thu Jan 7, 4:45PM CST
OPKO Health (OPK) closed the most recent trading day at $4.48, moving +1.82% from the previous trading session.
OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire - Tue Jan 5, 7:00AM CST CMTX - Tue Jan 5, 7:00AM CST
OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39 Annual J.P. Morgan Healthcare Conference being held virtually on January 11-14, 2021. Management will be...
OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide PR Newswire - PRF - Mon Jan 4, 11:05AM CST CMTX - Mon Jan 4, 11:05AM CST
, /PRNewswire/ --Â BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:Â OPK), today announced the results of COVID-19 molecular PCR tests for public schools throughout boroughs, with a positivity...
OPKO Health's (OPK) BioReference Starts Fan Testing Program Zacks - Mon Jan 4, 10:07AM CST Zacks Equity Research - ZACKS - Mon Jan 4, 10:07AM CST
OPKO Health's (OPK) BioReference commences mandatory, large-scale COVID-19 testing programs for fans for AFC Division Wild Card playoff game.
